Mark G. Currie
Chief Scientific Officer, Ironwood Pharmaceuticals.
Companies
- Ironwood PharmaceuticalsBoard member Apr 3, 2019 to now1
- Korsana Biosciences, Inc.President Apr 3, 2019 to Dec 30, 20202
- Ironwood PharmaceuticalsChief Scientific Officer Feb 2, 2010 to Mar 8, 20193
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Ironwood Pharmaceuticals IRWD676,900 shares4$2.4M at $3.52Jun 16, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 16, 2026Granted 63,481 shares of Ironwood Pharmaceuticals4
- Jun 10, 2025Granted 45,000 shares of Ironwood Pharmaceuticals5
- Jun 18, 2024Granted 24,311 shares of Ironwood Pharmaceuticals6
- Jun 20, 2023Granted 22,350 shares of Ironwood Pharmaceuticals7
- Aug 11, 2022Sold 70,000 shares at $11.78 of Ironwood Pharmaceuticals8
- Jun 7, 2022Sold 190,383 shares at $12.01 of Ironwood Pharmaceuticals9
- Jun 7, 2022Exercised options 190,383 shares at $11.65 of Ironwood Pharmaceuticals9
- Jun 1, 2022Granted 21,571 shares of Ironwood Pharmaceuticals10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARKorsana Biosciences, Inc., President
- 3
- 4
- 5SEC EDGARForm 4 filed Jun 12, 2025
- 6SEC EDGARForm 4 filed Jun 21, 2024
- 7SEC EDGARForm 4 filed Jun 22, 2023
- 8SEC EDGARForm 4 filed Aug 15, 2022
- 9SEC EDGARForm 4 filed Jun 9, 2022
- 10SEC EDGARForm 4 filed Jun 3, 2022